產品名稱 |
KCL22-s |
商品貨號 |
B161700 |
Organism |
Homo sapiens, human |
Tissue |
pleural effusion, bone marrow |
Product Format |
frozen 1.0 mL |
Morphology |
lymphoblast-like |
Culture Properties |
suspension |
Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Disease |
chronic myeloid leukemia at blast crisis |
Age |
32 years |
Gender |
female |
Applications |
The paired KCL22-s and KCL22-r clones are useful cell line models of sensitivity and resistance to a tyrosine kinase inhibitor used in the treatment of chronic myeloid leukemia. |
Storage Conditions |
liquid nitrogen vapor phase |
Images |
|
Comments |
BCR-ABL of the e13a2 fusion transcript type. |
Complete Growth Medium |
The base medium for this cell line is RPMI-1640 (ATCC 30-2001). To make the complete medium add to 500 mL of the base medium:
- 56 mL Fetal Bovine Serum (FBS; ATCC 30-2020)
- 5.6 mL L-glutamine (ATCC 30-2214)
|
Subculturing |
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 3 X 105 cells/mL and maintain between 1.0 X 105 and 1.5 X 106 cells/mL.
Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density). |
Cryopreservation |
Complete culture medium + 10% DMSO (ATCC 4-X) |
Culture Conditions |
Atmosphere: air, 95%; carbon dioxide (CO2), 5% CO2
Temperature: 37°C |
Volume |
1.0 mL |
STR Profile |
Amelogenin: X
CSF1PO: 11,12
D13S317: 8
D16S539:11,12
D5S818: 10,11
D7S820: 12
THO1: 7,9
TPOX: 8
vWA: 14 |
Sterility Tests |
Bacteria and yeast: No growth
Mycoplasma: No growth |
Viral Testing |
Hepatitis B: None detected
Cytomegalovirus: None detected
Human immunodeficiency virus: None detected
Epstein-Barr virus: None detected
Human papillomavirus: None detected
|
Population Doubling Time |
24 to 30 hours |
Name of Depositor |
J Vaz de Melo, Dept of Hematology, Royal Adelaide Hospital, Australia |
Year of Origin |
1999 |
References |
Tipping AJ, et al. Comparative gene expression profile of chronic myeloid leukemia cells innately resistant to imatinib mesylate. Exp Hematol 31(11):1073-80, 2003. PubMed: 14585372
Kubonishi I, et al. Establishment of a Ph1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis. Int J Cell Cloning 1(2):105-17, 1983. PubMed: 3461189
Kubonishi I, et al. Two new Human Myeloid Cell Lines Derived from Acute Promyelo-cytic Leukemia and Chromic myelocytic leukemia. Gan 74: 319-322 1983. PubMed: 6576961
|